Prices as of 2026-04-02 16:15:52 ET
Ticker Appearances
Daily Technical Strategy
Chinese Equities start to outperform SPX with falling Dollar & Bifurcation within US Technology
NEAR-TERM EQUITY TRENDS ARE SHORT-TERM BULLISH, AND BOTH SPX AND QQQ HAVE PUSHED BACK TO NEW ALL-TIME HIGHS WHILE THE BROADER MARKET HAS REMAINED FAR...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Healthcare being raised to Overweight after breakout
NEAR-TERM EQUITY TRENDS ARE BULLISH, AND IT’S EXPECTED THAT QQQ WILL SOON BREAK OUT TO JOIN THE MOVE BACK TO NEW HIGHS, WHICH HAS BEEN...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Medical Device names now breaking out to join Biotechnology
NEAR-TERM TREND REMAINS NEGATIVE FOR SPX UNTIL 6770 CAN BE EXCEEDED, AND DESPITE THE TWO-DAY BOUNCE, MORE WILL BE NEEDED TO HELP RESTORE THE TECHNICAL...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - May 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Technical Strategy
LIVE Technical Stock Analysis - April 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - February 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Emerging markets could bounce into End-of-Yr. as DXY decline continues
EQUITY TRENDS FROM AUGUST REMAIN BULLISH, AND SPX HAS NEARED THE UPPER EDGE OF ITS FOUR-MONTH CHANNEL RESISTANCE WHILE THE NASDAQ 100 INDEX HAS JUST...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Healthcare on the verge of breaking out to new All-time highs on an Equal-weighted basis
THE RECENT STALLING OUT IN MOST US EQUITY INDICES OVER THE LAST WEEK HASN’T TAKEN AWAY FROM THE APPEAL OF THE CURRENT RALLY FROM EARLY...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Minor Bond yield breakout results in SPX selloff to near support
I CONTINUE TO SEE THE US STOCK MARKET AS BEING ATTRACTIVE, TECHNICALLY SPEAKING, AND DO NOT FEEL SUFFICIENT RISK IS THERE TO WARRANT A SELLOFF...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Healthcare should soon hit support and reverse in February
January’s strong gains suggest that the bullish Pre-election year seasonality trends likely outweigh the bearish forecasts about how dismal earnings should be, and the NASDAQ...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Chinese Equities start to outperform SPX with falling Dollar & Bifurcation within US Technology
NEAR-TERM EQUITY TRENDS ARE SHORT-TERM BULLISH, AND BOTH SPX AND QQQ HAVE PUSHED BACK TO NEW ALL-TIME HIGHS WHILE THE BROADER MARKET HAS REMAINED FAR...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Healthcare being raised to Overweight after breakout
NEAR-TERM EQUITY TRENDS ARE BULLISH, AND IT’S EXPECTED THAT QQQ WILL SOON BREAK OUT TO JOIN THE MOVE BACK TO NEW HIGHS, WHICH HAS BEEN...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Medical Device names now breaking out to join Biotechnology
NEAR-TERM TREND REMAINS NEGATIVE FOR SPX UNTIL 6770 CAN BE EXCEEDED, AND DESPITE THE TWO-DAY BOUNCE, MORE WILL BE NEEDED TO HELP RESTORE THE TECHNICAL...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - May 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Technical Strategy
LIVE Technical Stock Analysis - April 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - February 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Emerging markets could bounce into End-of-Yr. as DXY decline continues
EQUITY TRENDS FROM AUGUST REMAIN BULLISH, AND SPX HAS NEARED THE UPPER EDGE OF ITS FOUR-MONTH CHANNEL RESISTANCE WHILE THE NASDAQ 100 INDEX HAS JUST...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Healthcare on the verge of breaking out to new All-time highs on an Equal-weighted basis
THE RECENT STALLING OUT IN MOST US EQUITY INDICES OVER THE LAST WEEK HASN’T TAKEN AWAY FROM THE APPEAL OF THE CURRENT RALLY FROM EARLY...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Minor Bond yield breakout results in SPX selloff to near support
I CONTINUE TO SEE THE US STOCK MARKET AS BEING ATTRACTIVE, TECHNICALLY SPEAKING, AND DO NOT FEEL SUFFICIENT RISK IS THERE TO WARRANT A SELLOFF...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Healthcare should soon hit support and reverse in February
January’s strong gains suggest that the bullish Pre-election year seasonality trends likely outweigh the bearish forecasts about how dismal earnings should be, and the NASDAQ...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Chinese Equities start to outperform SPX with falling Dollar & Bifurcation within US Technology
NEAR-TERM EQUITY TRENDS ARE SHORT-TERM BULLISH, AND BOTH SPX AND QQQ HAVE PUSHED BACK TO NEW ALL-TIME HIGHS WHILE THE BROADER MARKET HAS REMAINED FAR...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Healthcare being raised to Overweight after breakout
NEAR-TERM EQUITY TRENDS ARE BULLISH, AND IT’S EXPECTED THAT QQQ WILL SOON BREAK OUT TO JOIN THE MOVE BACK TO NEW HIGHS, WHICH HAS BEEN...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Medical Device names now breaking out to join Biotechnology
NEAR-TERM TREND REMAINS NEGATIVE FOR SPX UNTIL 6770 CAN BE EXCEEDED, AND DESPITE THE TWO-DAY BOUNCE, MORE WILL BE NEEDED TO HELP RESTORE THE TECHNICAL...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - May 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Technical Strategy
LIVE Technical Stock Analysis - April 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - February 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Emerging markets could bounce into End-of-Yr. as DXY decline continues
EQUITY TRENDS FROM AUGUST REMAIN BULLISH, AND SPX HAS NEARED THE UPPER EDGE OF ITS FOUR-MONTH CHANNEL RESISTANCE WHILE THE NASDAQ 100 INDEX HAS JUST...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Healthcare on the verge of breaking out to new All-time highs on an Equal-weighted basis
THE RECENT STALLING OUT IN MOST US EQUITY INDICES OVER THE LAST WEEK HASN’T TAKEN AWAY FROM THE APPEAL OF THE CURRENT RALLY FROM EARLY...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Minor Bond yield breakout results in SPX selloff to near support
I CONTINUE TO SEE THE US STOCK MARKET AS BEING ATTRACTIVE, TECHNICALLY SPEAKING, AND DO NOT FEEL SUFFICIENT RISK IS THERE TO WARRANT A SELLOFF...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 0 [max_usage] => 2 [max_usage_crypto] => 2 )
